Skip to content

MEPHARMA

Active
Private limited companyfounded 2010active for 16 yearsHundelgemsesteenweg 652, 9820 Merelbeke-Melle, BelgiumKBO/BCE: BE 0827.027.443
Summary

MEPHARMA has been active since 2010 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €453,300 and a net result of €60,000. Equity is growing by about 26% per year across the filed financial years. Its solvency ranks better than 77% of 12,519 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

History

MEPHARMA was incorporated on 29 June 2010.1 Total assets went from €707,103 in 2018 to €701,341 in 2025 and headcount from 2 to 1.2 full-time equivalents.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2018 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
25-09
NBB filing Annual accounts filed
financial year 2025 · abbreviated format · 56 days late
2025
12-08
NBB filing Annual accounts filed
financial year 2024 · abbreviated format · 12 days late
2024
17-09
NBB filing Annual accounts filed
financial year 2023 · abbreviated format · 48 days late
2023
15-11
NBB filing Annual accounts filed
financial year 2022 · abbreviated format · 107 days late
2022
31-12
Financial Highest result from 2018 to 2025net €69,195 ▲14.4%
Operating result €113,155, net result €69,195, both a record.
31-12
Financial Equity above €200,000equity €268,265 ▲34.8%
3 profitable years in a row build equity to €268,265.
25-11
NBB filing Annual accounts filed
financial year 2021 · abbreviated format · 117 days late
2021
31-12
Financial Equity above €150,000equity €199,070 ▲43.7%
2 profitable years in a row build equity to €199,070.
20-12
NBB filing Annual accounts filed
financial year 2020 · abbreviated format · 142 days late
2020
31-12
Financial Back to profitnet €38,699
Net result €38,699 after one loss-making year.
31-12
Financial Liquidity more than doubledcurrent ratio 17.33
Current ratio from 6.22 to 17.33; short-term debt falls from €81,552 to €30,118.
31-12
Financial Equity above €100,000equity €138,569 ▲38.7%
Equity rises from €99,870 to €138,569.
Show earlier events
22-11
NBB filing Annual accounts filed
financial year 2019 · abbreviated format · 114 days late
2019
31-12
Financial Weakest financial yearnet -€22,836
Net result drops to -€22,836, the lowest in the series; recovery starts the following year.
09-10
NBB filing Annual accounts filed
financial year 2018 · abbreviated format · 70 days late
2018
25-09
NBB filing Annual accounts filed
financial year 2017 · abbreviated format · 56 days late
2017
29-09
NBB filing Annual accounts filed
financial year 2016 · abbreviated format · 60 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 15 annual accounts filed, the latest 10 are here; all 15 are under Financials.
0 of 3 deeds read
About the unread acts

We know of 3 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.